These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 32593233)
1. Critical evaluation of different available guidelines for late-onset hypogonadism. Giagulli VA; Castellana M; Lisco G; Triggiani V Andrology; 2020 Nov; 8(6):1628-1641. PubMed ID: 32593233 [TBL] [Abstract][Full Text] [Related]
2. Late-onset hypogonadism: a concept comes of age. Nieschlag E Andrology; 2020 Nov; 8(6):1506-1511. PubMed ID: 31639279 [TBL] [Abstract][Full Text] [Related]
3. European Association of Urology Position Statement on the Role of the Urologist in the Management of Male Hypogonadism and Testosterone Therapy. Mirone V; Debruyne F; Dohle G; Salonia A; Sofikitis N; Verze P; Fode M; Chapple C; Eur Urol; 2017 Aug; 72(2):164-167. PubMed ID: 28249799 [TBL] [Abstract][Full Text] [Related]
4. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. Bhasin S; Brito JP; Cunningham GR; Hayes FJ; Hodis HN; Matsumoto AM; Snyder PJ; Swerdloff RS; Wu FC; Yialamas MA J Clin Endocrinol Metab; 2018 May; 103(5):1715-1744. PubMed ID: 29562364 [TBL] [Abstract][Full Text] [Related]
5. Late-onset Hypogonadism: Bone health. Rochira V Andrology; 2020 Nov; 8(6):1539-1550. PubMed ID: 32469467 [TBL] [Abstract][Full Text] [Related]
6. Late-onset hypogonadism: Prostate safety. Miranda EP; Torres LO Andrology; 2020 Nov; 8(6):1606-1613. PubMed ID: 32056383 [TBL] [Abstract][Full Text] [Related]
7. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale. Lunenfeld B; Saad F; Hoesl CE Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160 [TBL] [Abstract][Full Text] [Related]
9. Late-onset hypogonadism: Reductio ad absurdum of the cardiovascular risk-benefit of testosterone replacement therapy. Sesti F; Pofi R; Minnetti M; Tenuta M; Gianfrilli D; Isidori AM Andrology; 2020 Nov; 8(6):1614-1627. PubMed ID: 32737921 [TBL] [Abstract][Full Text] [Related]
10. Testosterone Deficiency: A Review and Comparison of Current Guidelines. Kwong JCC; Krakowsky Y; Grober E J Sex Med; 2019 Jun; 16(6):812-820. PubMed ID: 31080101 [TBL] [Abstract][Full Text] [Related]
12. The International Society for Sexual Medicine's Process of Care for the Assessment and Management of Testosterone Deficiency in Adult Men. Dean JD; McMahon CG; Guay AT; Morgentaler A; Althof SE; Becher EF; Bivalacqua TJ; Burnett AL; Buvat J; El Meliegy A; Hellstrom WJ; Jannini EA; Maggi M; McCullough A; Torres LO; Zitzmann M J Sex Med; 2015 Aug; 12(8):1660-86. PubMed ID: 26081680 [TBL] [Abstract][Full Text] [Related]
13. Use of Hormone Testing for the Diagnosis and Evaluation of Male Hypogonadism and Monitoring of Testosterone Therapy: Application of Hormone Testing Guideline Recommendations in Clinical Practice. Muram D; Zhang X; Cui Z; Matsumoto AM J Sex Med; 2015 Sep; 12(9):1886-94. PubMed ID: 26272690 [TBL] [Abstract][Full Text] [Related]
14. Testosterone therapy: where do the latest guidelines agree and differ? Pelzman DL; Hwang K Curr Opin Endocrinol Diabetes Obes; 2020 Dec; 27(6):397-403. PubMed ID: 33044244 [TBL] [Abstract][Full Text] [Related]
15. Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE). Isidori AM; Aversa A; Calogero A; Ferlin A; Francavilla S; Lanfranco F; Pivonello R; Rochira V; Corona G; Maggi M J Endocrinol Invest; 2022 Dec; 45(12):2385-2403. PubMed ID: 36018454 [TBL] [Abstract][Full Text] [Related]
16. Is Testosterone the "Fountain of Youth" for Aging Men? Giagulli VA; Lisco G; Mariano F; De Tullio A; Triggiani V Endocr Metab Immune Disord Drug Targets; 2023; 23(2):169-178. PubMed ID: 35578868 [TBL] [Abstract][Full Text] [Related]
17. Outcomes of androgen replacement therapy in adult male hypogonadism: recommendations from the Italian society of endocrinology. Isidori AM; Balercia G; Calogero AE; Corona G; Ferlin A; Francavilla S; Santi D; Maggi M J Endocrinol Invest; 2015 Jan; 38(1):103-12. PubMed ID: 25384570 [TBL] [Abstract][Full Text] [Related]
18. British Society for Sexual Medicine Guidelines on Adult Testosterone Deficiency, With Statements for UK Practice. Hackett G; Kirby M; Edwards D; Jones TH; Wylie K; Ossei-Gerning N; David J; Muneer A J Sex Med; 2017 Dec; 14(12):1504-1523. PubMed ID: 29198507 [TBL] [Abstract][Full Text] [Related]
19. EMAS position statement: Testosterone replacement therapy in the aging male. Dimopoulou C; Ceausu I; Depypere H; Lambrinoudaki I; Mueck A; Pérez-López FR; Rees M; van der Schouw YT; Senturk LM; Simonsini T; Stevenson JC; Stute P; Goulis DG Maturitas; 2016 Feb; 84():94-9. PubMed ID: 26614257 [TBL] [Abstract][Full Text] [Related]
20. Aromatase inhibitors and selective estrogen receptor modulators: Unconventional therapies for functional hypogonadism? Awouters M; Vanderschueren D; Antonio L Andrology; 2020 Nov; 8(6):1590-1597. PubMed ID: 31696669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]